Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
… will be presenting an epidemiologist perspective on true adverse reactions in pharma research at the DIA, Global Forum for Qualified Persons for Pharmacovigilance. True adverse reaction or not: that’s the question. Epidemiology …
… Institute for Health and Care Excellence (NICE), and Food and Drug Administration (FDA), resulting in deeper … settings examining the experiences of people living with cancer and their lives, with a focus on the impact of cancer … of psychology teams, collecting and using patient-reported outcome data as part of a neuropsychological assessment. …
… through to transfusion. They found that the risk of adverse events was small for both methods, but the difference …
… Their focus includes such areas as pharmacovigilance, drug utilization research, comparative effectiveness review, and therapeutic risk management. Pharmacoepidemiology … is the science that applies epidemiologic approaches to studying the use, effectiveness, value, and safety of …
… for over a decade in fields like HIV, cardiovascular, and cancer research. In this study, we explored an alternative … used the emulation of a target trial of breast cancer screening using Medicare claims data: we estimated, in … women over 70 years old who were just screened for breast cancer, what was the effect of stopping screening vs. …
… from the event: Genomic/Biomarker Data: Revolutionizing Cancer Treatment There is a push to increase the awareness … real-world data is transforming how we assess and optimize cancer treatments. Application of AI for Efficient Clinical … of the oncology community to push the boundaries of cancer treatment. At RTI-HS, we are committed to supporting …
… invasive fungal infections, migraine, non-small cell lung cancer, ovarian cancer, Parkinson’s disease, pertussis, renal … , and Psychiatric Services. Ms. Meyers also provides peer review for manuscript submissions in various peer reviewed … and Persistence (ESPACOMP); International Congress on Drug Therapy in HIV Infection; the European AIDS conference; …
… and western Europe: a real-world observational chart review study. Goyal RK, Frugier G, Rombi J, Esterberg L, … of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenocarcinoma (EAC): 36-month …
… challenges in designing conceptual models for biologic therapies in eosinophilic-associated diseases. We performed a … identifying appropriate treatment stopping rules, finding publications reporting stratified cost and utility estimates, …
… bring more equity to health technology assessments (HTAs), drug and medical device developers are looking to understand … might be thinking of prioritising the larger indication therapies, because the IRA clock starts with the first … to address potential challenges they may face in drug development as they move toward regulatory approval and …